Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing

BackgroundMultiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system to which a genetic predisposition contributes. Over 200 genetic regions have been associated with increased disease risk, but the disease-causing variants and their functional impact at the molecular...

Full description

Bibliographic Details
Main Authors: Elena Putscher, Michael Hecker, Brit Fitzner, Nina Boxberger, Margit Schwartz, Dirk Koczan, Peter Lorenz, Uwe Klaus Zettl
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.931831/full
_version_ 1811334918326714368
author Elena Putscher
Michael Hecker
Brit Fitzner
Nina Boxberger
Margit Schwartz
Dirk Koczan
Peter Lorenz
Uwe Klaus Zettl
author_facet Elena Putscher
Michael Hecker
Brit Fitzner
Nina Boxberger
Margit Schwartz
Dirk Koczan
Peter Lorenz
Uwe Klaus Zettl
author_sort Elena Putscher
collection DOAJ
description BackgroundMultiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system to which a genetic predisposition contributes. Over 200 genetic regions have been associated with increased disease risk, but the disease-causing variants and their functional impact at the molecular level are mostly poorly defined. We hypothesized that single-nucleotide polymorphisms (SNPs) have an impact on pre-mRNA splicing in MS.MethodsOur study focused on 10 bioinformatically prioritized SNP–gene pairs, in which the SNP has a high potential to alter alternative splicing events (ASEs). We tested for differential gene expression and differential alternative splicing in B cells from MS patients and healthy controls. We further examined the impact of the SNP genotypes on ASEs and on splice isoform expression levels. Novel genotype-dependent effects on splicing were verified with splicing reporter minigene assays.ResultsWe were able to confirm previously described findings regarding the relation of MS-associated SNPs with the ASEs of the pre-mRNAs from GSDMB and SP140. We also observed an increased IL7R exon 6 skipping when comparing relapsing and progressive MS patients to healthy subjects. Moreover, we found evidence that the MS risk alleles of the SNPs rs3851808 (EFCAB13), rs1131123 (HLA-C), rs10783847 (TSFM), and rs2014886 (TSFM) may contribute to a differential splicing pattern. Of particular interest is the genotype-dependent exon skipping of TSFM due to the SNP rs2014886. The minor allele T creates a donor splice site, resulting in the expression of the exon 3 and 4 of a short TSFM transcript isoform, whereas in the presence of the MS risk allele C, this donor site is absent, and thus the short transcript isoform is not expressed.ConclusionIn summary, we found that genetic variants from MS risk loci affect pre-mRNA splicing. Our findings substantiate the role of ASEs with respect to the genetics of MS. Further studies on how disease-causing genetic variants may modify the interactions between splicing regulatory sequence elements and RNA-binding proteins can help to deepen our understanding of the genetic susceptibility to MS.
first_indexed 2024-04-13T17:16:22Z
format Article
id doaj.art-33ac74953c38475e8339f0e7878270cc
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T17:16:22Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-33ac74953c38475e8339f0e7878270cc2022-12-22T02:38:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.931831931831Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicingElena Putscher0Michael Hecker1Brit Fitzner2Nina Boxberger3Margit Schwartz4Dirk Koczan5Peter Lorenz6Uwe Klaus Zettl7Rostock University Medical Center, Department of Neurology, Division of Neuroimmunology, Rostock, GermanyRostock University Medical Center, Department of Neurology, Division of Neuroimmunology, Rostock, GermanyRostock University Medical Center, Department of Neurology, Division of Neuroimmunology, Rostock, GermanyRostock University Medical Center, Department of Neurology, Division of Neuroimmunology, Rostock, GermanyRostock University Medical Center, Department of Neurology, Division of Neuroimmunology, Rostock, GermanyRostock University Medical Center, Institute of Immunology, Rostock, GermanyRostock University Medical Center, Institute of Immunology, Rostock, GermanyRostock University Medical Center, Department of Neurology, Division of Neuroimmunology, Rostock, GermanyBackgroundMultiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system to which a genetic predisposition contributes. Over 200 genetic regions have been associated with increased disease risk, but the disease-causing variants and their functional impact at the molecular level are mostly poorly defined. We hypothesized that single-nucleotide polymorphisms (SNPs) have an impact on pre-mRNA splicing in MS.MethodsOur study focused on 10 bioinformatically prioritized SNP–gene pairs, in which the SNP has a high potential to alter alternative splicing events (ASEs). We tested for differential gene expression and differential alternative splicing in B cells from MS patients and healthy controls. We further examined the impact of the SNP genotypes on ASEs and on splice isoform expression levels. Novel genotype-dependent effects on splicing were verified with splicing reporter minigene assays.ResultsWe were able to confirm previously described findings regarding the relation of MS-associated SNPs with the ASEs of the pre-mRNAs from GSDMB and SP140. We also observed an increased IL7R exon 6 skipping when comparing relapsing and progressive MS patients to healthy subjects. Moreover, we found evidence that the MS risk alleles of the SNPs rs3851808 (EFCAB13), rs1131123 (HLA-C), rs10783847 (TSFM), and rs2014886 (TSFM) may contribute to a differential splicing pattern. Of particular interest is the genotype-dependent exon skipping of TSFM due to the SNP rs2014886. The minor allele T creates a donor splice site, resulting in the expression of the exon 3 and 4 of a short TSFM transcript isoform, whereas in the presence of the MS risk allele C, this donor site is absent, and thus the short transcript isoform is not expressed.ConclusionIn summary, we found that genetic variants from MS risk loci affect pre-mRNA splicing. Our findings substantiate the role of ASEs with respect to the genetics of MS. Further studies on how disease-causing genetic variants may modify the interactions between splicing regulatory sequence elements and RNA-binding proteins can help to deepen our understanding of the genetic susceptibility to MS.https://www.frontiersin.org/articles/10.3389/fimmu.2022.931831/fullB cellsgenetic disease risksplicing reporter minigene assaymultiple sclerosissingle-nucleotide polymorphismsTSFM
spellingShingle Elena Putscher
Michael Hecker
Brit Fitzner
Nina Boxberger
Margit Schwartz
Dirk Koczan
Peter Lorenz
Uwe Klaus Zettl
Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
Frontiers in Immunology
B cells
genetic disease risk
splicing reporter minigene assay
multiple sclerosis
single-nucleotide polymorphisms
TSFM
title Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
title_full Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
title_fullStr Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
title_full_unstemmed Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
title_short Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
title_sort genetic risk variants for multiple sclerosis are linked to differences in alternative pre mrna splicing
topic B cells
genetic disease risk
splicing reporter minigene assay
multiple sclerosis
single-nucleotide polymorphisms
TSFM
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.931831/full
work_keys_str_mv AT elenaputscher geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing
AT michaelhecker geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing
AT britfitzner geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing
AT ninaboxberger geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing
AT margitschwartz geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing
AT dirkkoczan geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing
AT peterlorenz geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing
AT uweklauszettl geneticriskvariantsformultiplesclerosisarelinkedtodifferencesinalternativepremrnasplicing